This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Cramer: Fed Up With the Parlor Games

Stocks in this article: NDLSONXX

Editor's Note: This article was originally published at 6 a.m. EDT on Real Money on July 2. To see Jim Cramer's latest commentary as it's published, sign up for a free trial of Real Money.

NEW YORK ( Real Money) -- Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Fed guessing game is going. Only then do I look at how stocks are doing.

I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.

But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.

Fortunately I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Our Tweets

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs